Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

23. September 2016 01:38 ET | Quelle: AC Immune SA

Switzerland's AC Immune Opens For Trading On NASDAQ

SWITZERLAND'S AC IMMUNE OPENS FOR TRADING ON NASDAQ Lausanne, Switzerland, September 23, 2016 - AC Immune SA, a Swiss-based, clinical stage biopharmaceutical company focused on neurodegenerative...
22. September 2016 18:21 ET | Quelle: AC Immune SA

AC Immune SA Announces Pricing of Upsized Initial Public Offering

AC Immune Announces Pricing of Upsized Initial Public Offering Lausanne, Switzerland - September 23, 2016 - AC Immune SA announced today the pricing of its initial public offering of 6,000,000 of...
13. September 2016 16:53 ET | Quelle: AC Immune SA

AC Immune SA Commences Proposed Initial Public Offering of Common Shares

LAUSANNE, Switzerland, Sept. 13, 2016 (GLOBE NEWSWIRE) -- AC Immune SA announced today that it has commenced the initial public offering of 4,545,456 of its common shares pursuant to a registration...
13. September 2016 16:44 ET | Quelle: AC Immune SA

AC Immune SA Commences Proposed Initial Public Offering of Common Shares

AC Immune Commences Proposed Initial Public Offering of Common Shares Lausanne, Switzerland - September 13, 2016 - AC Immune SA announced today that it has commenced the initial public...

Vorherige Seite